Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Burisch

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
World Journal of Gastroenterology|November 6, 2019
Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology studyRavi Misra, Jimmy Limdi, Rachel Cooney, et al.
Inflammatory Bowel Diseases|September 24, 2014
eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitisNatalia Pedersen, Peter Thielsen, Lars Martinsen, et al.
Digestive Diseases and Sciences|April 15, 2025
Musculoskeletal Symptoms and Clinical Findings in Bio-naïve Patients with Inflammatory Bowel Disease Prior to Biological Treatment Initiation: A Prospective Cohort StudyNora Vladimirova, Mirabella Zhao, Lykke Midtbøll Ørnbjerg, et al.
Scandinavian Journal of Gastroenterology|March 1, 2021
Costs of electronic health vs. standard care management of inflammatory bowel disease across three years of follow-up-a Danish register-based studyDorit Vedel Ankersen, Petra Weimers, Dorte Marker, et al.
Scandinavian Journal of Gastroenterology|January 17, 2025
Health-related quality of life at diagnosis and follow-up in Faroese and Danish patients with inflammatory bowel disease - a Faroese IBD cohort studyTurid Hammer, Frederikke Agerbo Modin, Kári Rubek Nielsen, et al.
BMJ Open Gastroenterology|December 26, 2025
MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT)Camilla Frimor, Casper Steenholdt, Ella Signe Kassandra Widigson, et al.
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse OutcomesRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
Endoscopy International Open|April 8, 2020
Current challenges and future needs of clinical and endoscopic training in gastroenterology: a European surveyMarcello Maida, Laith Alrubaiy, Tomislav Bokun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2025
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease: A Copenhagen IBD Cohort StudyGorm Roager Madsen, Mohamed Attauabi, Johan F K F Ilvemark, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
World Journal of Gastroenterology|November 6, 2019
Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology studyRavi Misra, Jimmy Limdi, Rachel Cooney, et al.
Inflammatory Bowel Diseases|September 24, 2014
eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitisNatalia Pedersen, Peter Thielsen, Lars Martinsen, et al.
Digestive Diseases and Sciences|April 15, 2025
Musculoskeletal Symptoms and Clinical Findings in Bio-naïve Patients with Inflammatory Bowel Disease Prior to Biological Treatment Initiation: A Prospective Cohort StudyNora Vladimirova, Mirabella Zhao, Lykke Midtbøll Ørnbjerg, et al.
Scandinavian Journal of Gastroenterology|March 1, 2021
Costs of electronic health vs. standard care management of inflammatory bowel disease across three years of follow-up-a Danish register-based studyDorit Vedel Ankersen, Petra Weimers, Dorte Marker, et al.
Scandinavian Journal of Gastroenterology|January 17, 2025
Health-related quality of life at diagnosis and follow-up in Faroese and Danish patients with inflammatory bowel disease - a Faroese IBD cohort studyTurid Hammer, Frederikke Agerbo Modin, Kári Rubek Nielsen, et al.
BMJ Open Gastroenterology|December 26, 2025
MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT)Camilla Frimor, Casper Steenholdt, Ella Signe Kassandra Widigson, et al.
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse OutcomesRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
Endoscopy International Open|April 8, 2020
Current challenges and future needs of clinical and endoscopic training in gastroenterology: a European surveyMarcello Maida, Laith Alrubaiy, Tomislav Bokun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2025
Intestinal Ultrasound Findings and Their Prognostic Value in Early Crohn's Disease: A Copenhagen IBD Cohort StudyGorm Roager Madsen, Mohamed Attauabi, Johan F K F Ilvemark, et al.
Pageof 28